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Abstract 
BACKGROUND: Treatment-resistant depression (TRD) is a severe and chronic form of major depression. It poses 
significant clinical, personal, and economic burden and does not respond to antidepressants. Psychotherapy can 
be a suggested option. The aim of this study was to survey the effectiveness of cognitive behavioral therapy (CBT) 
on patients with TRD. 
METHODS: The present study was a quasi-experimental study with pretest, posttest, and follow-up. The statistical 
population included patients with TRD in Rafsanjan City, Iran, in 2018. 30 subjects were randomly selected and 
placed into experimental and control groups. Data were collected by Beck Depression Inventory (BDI), Rumination 
Questionnaire, and Brunel Mood Scale (BRUMS). To analyze data, multivariate analysis of covariance (MANCOVA) 
was used with SPSS software. 
RESULTS: CBT led to reducing depression and rumination and improving mood and this outcome was better than 
control group (P < 0.05). 
CONCLUSION: TRD is a chronic and disabling disorder that little research has been done about its treatment. CBT 
can be a good treatment offer for TRD. 
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Introduction1 
Major depressive disorder (MDD) is a common 
mental disorder, affecting over 300 million 
people worldwide.1 It has a great impact on the 
quality of life and patient functioning, and is 
regarded as an essential factor leading to 
disability worldwide. If left untreated, it can 
lead to serious consequences, with a lifetime 
suicide risk of 2.2%-15.0%.2 In 2015, depressive 
disorders were the greatest contributor to non-
fatal health loss.3 
Depression is a complex disorder with 
multiple symptomatological clusters, including 
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emotional, cognitive, and physical symptoms. 
Contemporary treatment goals are to control 
symptoms, achieve remission, and restore 
patients’ functioning level to baseline.3 
Increasing clinical evidence supports that 
approximately two thirds of patients with 
MDD fail to receive full remission, even after 
completing an adequate trial of antidepressant 
therapy.4 30%-50% of patients with MDD do 
not respond to antidepressant medications but 
can respond to psychological therapy.5 
Those who have failed to have an adequate 
response to the routine antidepressant therapy 
are usually considered as patients with 
treatment-resistant depression (TRD),6 which 
may result in psychophysiological compromise.5 
TRD is a form of severe depression,7 which 
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definition of it. Most definitions of failure in 
drug therapy refer to psychotherapy and other 
interventions.6 Patients with TRD often fail in 
several treatments with antidepressant 
standards and have an undesirable long-term 
prognosis, and it is estimated that there may be 
at least 10 million patients with TRD in United 
States of America (USA).8 
Aim of the treatment is fully functional 
recovery, which is defined as a state in which 
patients are again able to enjoy their usual 
activities, return to work, and take care of 
themselves, and it should represent the end 
goal of treatment in patients with MDD. 
Patients with depression report many unmet 
needs including residual cognitive symptoms 
and lack of improvement in psychosocial 
functioning and life satisfaction, even during 
mood symptom remission. A good 
antidepressant therapy is expected to improve 
affective symptoms, cognitive symptoms, 
psychosocial functioning, work functioning, 
and quality of life.9 
Moreover, the limitation of clinical therapies 
in United Kingdom (UK) and USA has led to 
the use of cognitive behavioral therapy (CBT) in 
the treatment of people who did not respond to 
drug treatments. In CBT for patients with 
depression, the techniques are aimed to correct 
their wrong belief that their lives are filled with 
failure, hopelessness, and uselessness.5 
CBT is based on the interrelationship of 
thoughts, actions, and feelings. In order to 
work with feelings of depression, this model 
establishes the importance of identifying the 
thoughts and actions that influence mood. In 
this manner, the adolescent learns to gain 
control of his/her feelings.10 
There is good widespread evidence of the 
effectiveness of CBT on depression, especially 
for previously-untreated periods of depression.  
The cognitive processes in this structure 
refer to the principles used in the processing of 
information in triggering confrontation.8 It can 
be said that perception, thoughts, mental 
imagery, and associated memories are 
cognitive consequences that result from the 
transformation of stimuli through cognitive 
processes. According to the cognitive 
approach, in the case of depression, negative 
schema has a major role in the incidence of 
depression and based on this approach, a set of 
negative schemas in a person causes an 
attitude of action failure and this deficiency 
causes or provokes resistance of person to 
depression. Based on these ideas, CBT 
emerged few decades ago, and was updated 
daily. Evidence suggests that defective 
cognitive processes are depressive factors and 
increase the vulnerability to the return of 
subsequent periods. One of these processes, 
mental ruminations, cause depression.11 
Ruminations are defined as resistant and 
recurring thoughts that circle around a common 
thread. These non-voluntary thoughts go into 
consciousness and divert attention from the 
issues and current goals.12 Many studies show 
the relationship between rumination and 
various types of emotional disorders. Mental 
rumination is a constant and species traits 
phenomena and it is a type of response that 
causes one's attention to be focused on causes, 
effects, and symptoms of depression. Usually, 
rumination induces mechanisms that turn into 
different risk factors for depression, and in fact, 
the pressure increases and social support, 
optimism, and neuroticism decrease.13 
Regarding the high prevalence of TRD, 
severity and chronicity of this disorder, and 
high costs and also considering personal, 
economic, and social aspects and lack of 
applied therapeutic methods for TRD in Iran, 
the purpose of this study was to survey the 
effectiveness of CBT on treatment of patient 
with TRD. 
Materials and Methods 
This study was a quasi-experimental research 
project with pre-test, post-test, and follow-up 
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Figure 1. Process of implementation of research 
project 
 
The research community included all the 
patients with TRD in Rafsanjan City, Iran, in 
2018. Among people that referred to 
psychiatrist or psychologist and were 
diagnosed with TRD, 30 persons were 
randomly selected among the volunteers for 
psychotherapy, and randomly assigned to 2 
groups (experimental and control). The 
experimental group participated in 5 sessions of 
CBT and the control group received 3 sessions 
of placebo. 
In this research, 3 questionnaires were used: 
Rumination Scale: Nolen-Hoeksema in 1991 
developed a self-study questionnaire that 
evaluated four different types of responses to 
negative mood. Based on empirical evidence, 
this scale has a high internal stability. Cronbach's 
alpha coefficient ranges from 0.88 to 0.92.13 
Beck Depression Inventory-II (BDI-II): This 
scale is an overviewed form of the BDI 
designed to measure the severity of depression. 
The questionnaire consists of 21 items, which 
ask respondents to rank the severity of the 
symptoms on a scale from zero to three. The 
studies on validity, reliability, and construct 
validity of BDI-II have yielded a desirable factor 
for this questionnaire.14 
Brunel Mood Scale (BRUMS): This scale has 
32 questions that measure eight subscales in the 
Likert scale of 5 options. Its subscales are 
vitality, calmness, happiness, tension, 
depression, anger, fatigue, and confusion. 
Validity of this scale in Iran was reported for 
whole questionnaire to be 0.78 to 0.88.15 
For analysis of data, descriptive statistics 
such as frequency, percentage, mean, and 
standard deviation (SD) and inferential 
statistics including multivariate analysis of 
covariance (MANCOVA), single-variable 
analysis of covariance (ANCOVA), and post-
test were used. Data were analyzed by SPSS 
software (version 22, IBM Corporation, 
Armonk, NY, USA). 
Results 
Table 1 shows the demographic characteristics 
of the research sample. 
 
 
Table 1. Demographic parameters 







Perfect Good Moderate Weak Man Woman Widow Married Single 
CBT  1 5 9 1 4 10 0 4 11 0 13 2 
Control 2 4 9 0 4 9 2 3 12 1 12 2 
CBT: Cognitive behavioral therapy 
 
All patients with 
treatment-resistant 
depression (TRD) 
Diagnosed by a 
psychiatrist and two 
psychologists and 
randomly selected in 
Rafsanjan, Iran, 2018 
The criteria for entry in this study were as age 
range of 18 to 55 years, taking medication for at 
least 10 weeks and using their drug orders 
offered, getting a score of at least 14 in the Beck 
Depression Inventory (BDI) 
Random selection of 30 
volunteers for psychotherapy 
Exclusion criteria included people 
with bipolar disorder, psychosis, 
obsessive-compulsive disorder 
(OCD), drug abuse and people 
who have received psychological 
treatment at least since last year. 
Experimental group (n = 15) 
5 sessions of cognitive 
behavioral therapy (CBT) 
 
Control group (n = 15)  
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Table 2. Mean and standard deviation (SD) of groups in the variables 
Group Mood Rumination Depression 
CBT Pre-test 59.00 ± 7.60 46.00 ± 8.45 47.26 ± 2.18 
Post-test 31.28 ± 21.41 23.80 ± 6.13 20.00 ± 6.41 
Follow-up 21.06 ± 5.53 22.86 ± 5.99 17.80 ± 6.27 
Control Pre-test 75.00 ± 31.45 50.40 ± 9.05 54.93 ± 4.97 
Post-test 52.93 ± 5.50 48.60 ± 4.27 37.93 ± 13.56 
Follow-up 44.46 ± 4.62 51.60 ± 6.78 36.80 ± 11.02 
The values are presented as mean ± standard deviation (SD). 
CBT: Cognitive behavioral therapy 
 
 
Table 2 shows the mean and SD of the 
variables studied (mood, rumination, 
depression) in three stages (pre-test, post-test, 
and follow-up). 
The results of table 3 indicated that there 
was a significant difference between the 
experimental group and the control group in 
the three variables of depression, rumination, 
and mood in post-test level (P < 0.05). 
The results of table 4 indicated that there was 
a significant difference between the 
experimental group and the control group in 
the three variables of depression, rumination, 
and mood in follow-up level (P < 0.05).  
Discussion 
The average lifetime prevalence of MDD is 
estimated at 14.6% in high-income countries. It 
represents the leading cause of disability 
burden worldwide, accounting for 2.5%  
of global disability-adjusted life years  
(DALYs) lost.16  
30%-50% of patients with MDD do not 
respond to antidepressant medications and the 
diagnosis is TRD.8 
To concern the high prevalence of 
depression disorder in the general population 
and damage caused by TRD in a variety of 
economic, social, and health areas, a study on 
effective treatments is necessary. 
The aim of this study was to survey the 
effectiveness of CBT on TRD and aspects of 
depression especially rumination and mood. 
The findings show that CBT has a significant 
effect on depression, rumination, and mood 
compared to the control group. These results 
are consistent with the findings of Li et al.,17 
Franklin et al.,11 Proudfoot et al.,18 and Lopez 
and Basco.19 
Concerning the effectiveness of CBT, it can 
be explained that CBT, at first for changing the 
behavioral patterns of patients and increasing 
the positive reinforcement, leads to the lack of 
attention to some negative thoughts and 
prevents the deterioration of the mood, 
leading to an increase in targeted behavior and 
the ability to solve the problem.  
In particular, cognitive dysfunctions 
represent a key determinant of functional 
disability in patients with depression,  
which can persist beyond clinical symptom 
emission, limiting work functioning and 
contributing to the overall disability associated 
with MDD.20 
 
Table 3. Moderate mean and analysis of covariance (ANCOVA) in variables in the post-test 
Variable Group Moderate mean P F ETA coefficient 
Depression  CBT 10.43 < 0.01 24.39 0.83 
Control 43.80 
Rumination  CBT 10.34 < 0.01 17.82 0.67 
Control 41.46 
Mood CBT 37.30 < 0.01 58.80 0.88 
Control 17.40 
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Table 4. Moderate mean and analysis of covariance (ANCOVA) in variables in the follow-up 
Variable Group Moderate mean P F ETA coefficient 
Depression  CBT 9.13 < 0.01 24.39 0.97 
Control 48.51 
Rumination  CBT 15.44 < 0.01 17.82 0.64 
Control 36.62 
Mood CBT 43.30 < 0.01 58.80 0.79 
Control 19.10 
CBT: Cognitive behavioral therapy 
 
It has been extensively reported that not 
paying attention to the cognitive dimension in 
patients with depression may impair the 
achievement of full recovery. Cognitive-
behavioral approach is one of the methods that, 
having such training as assertiveness skills, 
leads to satisfaction of one's characteristics and 
abilities. Learning to do muscular relaxation 
and mental imagery also reduces the tension 
and pressure on external situations.5 
The individual, by learning the decision-
making and problem-solving skills, is able to 
influence and control the environment in a 
better and more positive way and increase 
individual adaptability. These skills also 
indirectly lead to enhanced self-esteem and 
self-satisfaction, improves the mood, and 
decreases rumination.20 
Considering the fact that this study was 
conducted only among patients with TRD in 
Rafsanjan, the results cannot be generalized to 
other patients with TRD in other parts of the 
country. Therefore, it is recommended to 
replicate this study in different populations 
throughout the country. It is also suggested to 
compare between CBT and other therapies to 
evaluate the effectiveness in TRD. Moreover, 
the gathered data were self-report and this was 
one of the limitations of the present study. 
Conclusion 
According to the results, it seems that CBT is 
the effective treatment for TRD, which 
decreases sings such as ruminations and 
improves the mood. It is expected that the 
findings of this study can be a useful step in 
the psychological treatment of patients with 
depression who are resistant to treatment and 
it is hoped that with psychological 
interventions, the rate of recovery of patients 
with depression will improve and the 
psychological and financial costs of the disease 
will decrease. 
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